AmStem is one of the world’s leading providers of cosmetic stem cell products, and is currently conducting several stem cell research tests and trials to create treatments for skin rejuvenation and for correcting several skin problems. The company recently conducted a study for SteMixx, a product that helps to improve the look and appearance of the skin, creates a more seven skin tone, and also helps reduce the signs of aging.
According to David Stark, President of AmStem International, Inc., “During the first few days, we asked participants of our initial consumer study of SteMixx™ for their initial impressions. We were not surprised but certainly pleased at how positively they responded.” Participants reported a number of positive effects, including the reduction of hyperpigmentation, less skin redness, clearer skin, tighter and less puffy skin, and a softer, more youthful complexion.
Twenty one women participated in the SteMixx™ study, and were asked not to use any other type of facial skin care products during the study period. Participants were permitted to use cleanser and sunscreen. The SteMixx™ product will now be available for retail consumers in the United States, and is currently being investigated by the Scottsdale Institute for Cosmetic Dermatology.
According to Dr. Shelly Friedman of the Scottsdale Institute for Cosmetic Dermatology, “This study will provide information to help decide what claims we will make in our labeling and advertising of SteMixx™”.
The SteMixx™ skin rejuvenation product and other cosmeceutical products from AmStem were developed by Dr. Han Hoon, CEO of Histostem, Ltd., in Seoul, Korea. The company operates one of the largest cord blood banks in the world. The SteMixx™ cream has been approved by the FDA in Korea for the treatment of facial skin disfiguration, including the signs of aging. The cream has not been reviewed by the FDA in the United States.
(Source: AmStem Press Release)